F2RL1 and cancer: Specifically, it would be pertinent to examine whether the OC-mediated downregulation of PAR-2 results in decreased expression or functional activity of ABC transporters, thereby augmenting the intracellular accumulation and cytotoxicity of co-administered anti-cancer drugs.